Franklin Genomic Advancements ETF (HELX) Chart & Stock Price History $28.04 +0.89 (+3.27%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Stock Price Performance The Franklin Genomic Advancements ETF (HELX) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 11.20%, with a year-to-date return of -3.08%. In the past month, the fund has increased 5.79%, reflecting recent market activity. As of the latest close, Franklin Genomic Advancements ETF traded at $28.05 with a market cap of $11.02 million and volume of 2,058 shares. Receive HELX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.43%1 Month Performance+5.79%3 Month Performance+12.69%Year-To-Date Performance-3.08%1 Year Performance-11.20% HELX Stock Chart for Saturday, July, 5, 2025 HELX Chart by TradingView Franklin Genomic Advancements ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/04/2025$28.05$28.05$27.55$27.552,058 shs$11.02 million07/03/2025$27.94$28.05+0.39%$27.55$27.552,058 shs$11.02 million07/02/2025$27.70$27.94+0.87%$27.55$27.552,058 shs$11.02 million07/01/2025$27.65$27.70+0.17%$27.55$27.552,058 shs$11.02 million06/30/2025$27.63$27.65+0.09%$27.55$27.552,058 shs$11.02 million06/27/2025$27.62$27.63+0.03%$27.55$27.552,058 shs$11.02 million06/26/2025$27.64$27.62-0.09%$27.55$27.552,058 shs$11.02 million06/25/2025$27.70$27.64-0.23%$27.55$27.552,058 shs$11.02 million06/24/2025$27.22$27.70+1.76%$27.55$27.552,058 shs$11.02 million06/23/2025$27.20$27.22+0.09%$27.55$27.552,058 shs$11.02 million Get the Latest News and Ratings for HELX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. 06/20/2025$27.23$27.20-0.10%$27.55$27.552,058 shs$11.02 million06/19/2025$27.23$27.23$27.55$27.552,058 shs$11.02 million06/18/2025$27.00$27.23+0.85%$27.55$27.552,058 shs$11.02 million06/17/2025$27.41$27.00-1.52%$27.55$27.552,058 shs$11.02 million06/16/2025$27.21$27.41+0.75%$27.55$27.552,058 shs$11.02 million06/13/2025$27.55$27.21-1.22%$27.55$27.552,058 shs$11.02 million06/12/2025$27.55$27.55+0.01%$27.55$27.552,058 shs$11.02 million06/11/2025$27.55$27.55$27.55$27.552,058 shs$11.02 million06/10/2025$26.92$27.55+2.32%$27.55$27.552,058 shs$11.02 million06/09/2025$26.86$26.92+0.24%$26.92$26.511,586 shs$10.64 million06/06/2025$26.51$26.86+1.31%$26.92$26.511,586 shs$10.64 million06/05/2025$26.82$26.51-1.16%$26.81$26.81220 shs$10.73 million06/04/2025$26.54$26.82+1.06%$26.54$26.50434 shs$10.60 million Related Companies AQWA Stock Price Chart NIKL Stock Price Chart SATO Stock Price Chart GXTG Stock Price Chart SPCX Stock Price Chart PSIL Stock Price Chart FIVY Stock Price Chart TOKE Stock Price Chart DMCY Stock Price Chart DYNI Stock Price Chart Receive HELX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. This page (BATS:HELX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
